Arthur Taveras insider trades
Open-market stock purchases and sales by Arthur Taveras, Chief Scientific Officer at X4 Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 30, 2020.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- XFOR X4 Pharmaceuticals, Inc: 6 sales, last Oct 7, 2024